Skip to main content
Log in

A chemical method for the labeling of fibrinogen with 99mTc

  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

A new method allowing the labelling of fibrinogen with 99mTcO -4 is described. The 99mTcO -4 is reduced by stannous chloride in an alkaline medium. After 1 h incubation with fibrinogen, the pH was brought down to 7.1. The study of (1) the pH of the solution, (2) the quantity of the reducer, and (3) the time of incubation allowed us to specify optimal conditions for labeling. The labeling yield varied from 91.68%±6.05% to 95.18%±2.13% according to the method of control used: the precipitation of fibrinogen by (NH4)2SO4 25% or thin-layer chromatography with methylethylketone as solvent. Clottable radioactivity averaged 72%±4.43%. Column chromatography separated the tracer into two radioactive peaks. The first peak corresponded to the fibrinogen and carried 73.36%±5.8% of the total radioactivity. The total recovered radioactivity amounted to 89.86%±8.07%. Spectroscopic clottability was 88.23%±2.42%.

The in vivo stability of the labeling and the molecule was followed for 24 h after intravenous injection. If the radioactivity measured in the 5 min sample was considered to equal 100%, the 24 h sample averaged 32.71%±3.25%, of which 85.68%±2.92% was recovered in the clot. In conclusion, this method enabled us to obtain a stable tracer that we used for routine investigations in man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abramovici, J., Jeghers, O., Ermans, A.M., Jonckheer, M.H., Szymusik, B.: Use of 99mTc fibrinogen in venous thrombosis. (Abstr.) Eur. J. Nucl. Med. 1, 83 (1976)

    Google Scholar 

  • Abramovici, J., Orloff, S., Jeghers, O., Jonckheer, M.: Use of 99mTechnetium fibrinogen in the diagnosis of reheumatoid arthritis. Presented at the 14th Int. Congr. Rheumatol., San Francisco, 1977

  • Campbell, R.M., Cuthbertson, D.P., Matthews, C.M., McFarlane, A.S.: Behavior of 14C- and 131I-labeled proteins in the rat. Int. J. Appl. Radiat. Isot. 1, 66–75 (1956)

    Article  CAS  Google Scholar 

  • Dreyer, R., Münze, R.: Markierung von Serumalbumin mit 99mTechnetium. Wiss. Z. Karl-Marx-Univ. Leipzig, Math.-Naturwiss. R. 18, 629–633 (1969)

    CAS  Google Scholar 

  • Dumortier, A., Jeghers, O., Abramovici, J.: Aspects radiopharmaceutiques du marquage du fibrinogène à l'aide du 99mTechnetium. Presented at the 33rd Int. Congr. Pharm. Sci. Stockholm, 1973

  • Eckelman, W.C., Meinken, G., Richards, P.: 99mTc-human serum albumin. J. Nucl. Med. 12, 707–710 (1971)

    CAS  PubMed  Google Scholar 

  • Harwig, J.F., Harwig, S.S.L., Wells, L.D., Welch, M.J.: Preparation and in vitro-properties of 99mTc-fibrinogen. Int. J. Appl. Radiat. Isot. 27, 5–13 (1976)

    Article  CAS  Google Scholar 

  • Hebestreit, H.P., Pryss, C.: 99mTc-Fibrinogen-Markierung mittels elektrolytischer Zirkon Freisetzung. Nucl. Med. 15, 2, 172–184 (1975)

    Google Scholar 

  • Hunter, W.M., Greenwood, F.C.: Preparation of 131I-labeled human growth hormone of high specific activity. Nature 194, 495–496 (1962)

    Article  CAS  Google Scholar 

  • Jean Williams, M., Deegan, T.: The processes involved in the binding of 99mTechnetium to human serum albumin. Int. J. Appl. Radiat. Isot. 22, 767–774 (1971)

    Article  Google Scholar 

  • Krohn, K., Sherman, L., Welch, M.: Studies of radioiodinated fibrinogen. 1. Physicochemical properties of the ICI, Chloramine-T and electrolytic reaction products. Biochim. Biophys. Acta 285, 404–413 (1972)

    Article  CAS  Google Scholar 

  • Laki, K.: The polymerization of proteins: the action of thrombin on fibrinogen. Arch. Biochem. Biophys. 32, 317–324 (1951)

    Article  CAS  Google Scholar 

  • Lamson, M., Callahan, R.J., Castronovo, F.P., McKusik, K.A., Potsaid, M.C.: A rapid index of free activity in preparation of 99mTc-albumin. J. Nucl. Med. 15, 1061–1063 (1974)

    PubMed  Google Scholar 

  • Lin, M.S., Winchell, H.S., Shipley, B.A.: Use of Fe(II) or Sn(II) alone for technetium labeling of albumin. J. Nucl. Med. 12, 204–211 (1971)

    CAS  PubMed  Google Scholar 

  • Lowry, P., Rosenbrough, N.J., Farr, A.L., Randall, R.J.: Protein measurement with the Folin phenol reagent. J. Biochem. Chem. 193, 265–275 (1951)

    CAS  Google Scholar 

  • Ly, B., Godal, H.C., Kierulf, P.: Thrombin clotting-time: a more sensitive indicator of denatured fibrinogen than clottability. Haemostasis 1, 44–51 (1972)

    CAS  PubMed  Google Scholar 

  • MacFarlane, A.S.: In vivo behaviour of 131I-fibrinogen. J. Clin. Invest. 42, 346–361 (1963)

    Article  Google Scholar 

  • Marchalonis, J.J.: An enzymatic method for the trace iodination of immunoglobulins and other proteins. Biochem. J. 113, 299–305 (1969)

    Article  CAS  Google Scholar 

  • Rosa, U., Scassellati, G.A., Pennisi, F., Riccioni, N., Giagnoni, P., Giordani, R.: Labelling of human fibrinogen with 131I by electrolytic iodination. Biochim. Biophys. Acta 86, 519–526 (1964)

    Article  CAS  Google Scholar 

  • Wong, D.W., Mishkin, F.S.: 99mTechnetium-human fibrinogen. J. Nucl. Med. 16, 343–347 (1975)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeghers, O., Abramovici, J., Jonckheer, M. et al. A chemical method for the labeling of fibrinogen with 99mTc. Eur J Nucl Med 3, 95–100 (1978). https://doi.org/10.1007/BF00251631

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00251631

Keywords

Navigation